<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Barrett oesophagus (BO) occurs as a consequence of prolonged <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> and it may precede the development of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: The aim of this study was to accurately assess Cdx2 expression in the oesophageal <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: The expression of the transcription factor Cdx2 in Barrett <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, high-grade <z:mp ids='MP_0002163'>glandular dysplasia</z:mp> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was investigated using immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The results confirmed previous immunohistochemistry and PCR-based investigations, indicating that Cdx2 was expressed by <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in the oesophagus </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, upregulation followed by linear downregulation of Cdx2 expression through the oesophageal <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence was demonstrated for the first time </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Such downregulation of Cdx2 expression could be in keeping with a role as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene, but a simpler explanation would be downregulation of a differentiation marker </plain></SENT>
</text></document>